The Marseille professor explained himself in an interview with Figaro Magazine on the effectiveness of hydroxychloroquine, conflicts of interest in the scientific community, and the decision taken by Emmanuel Macron not to reconfine.

The infectious disease specialist Didier Raoult spoke at length to Figaro Magazine, ahead of the publication on February 11, 2021, of his Covid-19 War Notebooks (ed. Michel Lafon). In an interview published on February 5, the director of the IHU Méditerranée in Marseille returned to the many debates he has provoked since the start of the Covid-19 pandemic.

Asked about any regrets in his past remarks, the scientist said he had none. While he had announced in the spring of 2020 that the epidemic was “in the process of disappearing”, he affirms to the weekly that he “maintains” this assertion. “The August virus is not that of spring: it is a new variant, which comes to us from Africa. Some people think I am playing on words. When we have been working on viral epidemics for forty years, we try to be precise, ”he explains.

Regarding hydroxychloroquine and its effectiveness against Covid-19, the Marseille professor explains that he “had to deal with bogus studies which confirmed the toxicity of this drug which has been administered to millions of patients for thirty years”. Didier Raoult refers in particular to the site, which “has carried out a meta-analysis of the 200 publications on hydroxychloroquine. It turns out that this is a drug that works quite well against the coronavirus. ” “I never said it was going to cure 100% of patients.

On the other hand, I maintain that this molecule improves the condition of precocious or advanced patients, but not in the final phase, ”he adds. “The president was right” The infectious disease specialist also points to conflicts of interest in the research community: “I’ve been refusing to work with the pharmaceutical industry for twenty years. Faced with it, the checks and balances are insignificant.

It is not normal for doctors to comment on drugs about which they have a conflict of interest. It’s astonishing because, in other sectors of society, this kind of attitude is no longer tolerated. ”

Finally, Didier Raoult welcomes Emmanuel Macron’s decision not to confine France (for now) in the face of the threat of variants. “The president was right. I have said it very often for a year: corrective social measures do not work because they create too much collateral damage. The risk-benefit is not satisfactory “, argues the scientist, according to which” the only thing that works in the control of the epidemic, it is the precocity of setting up of the tests and the isolation of the patients “.

Related: HCQ Peer-reviewed: Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection

Melbourne doctors urge officials to consider hydroxychloroquine, ivermectin in fight against COVID-19

Facebook Oversight Board admits Facebook was wrong to censor information about Hydroxychloroquine

Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk COVID-19 infection includes HCQ & Ivermectin

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Trouble in Paradise Surrounding the use of Ivermectin

In nations around the world tension mounts between physicians and caregivers seeking to prescribe what they professionally deem as safe doses of ivermectin, as an off-label treatment for COVID-19 and national health authorities, which for the most part have all taken a hostile and oppositional position against the use of the drug.

Read More »

How Ivermectin became a Target for the ‘Fraud Detectives.’

And why is ivermectin being so negatively targeted by Big Tech and Big Media? One could argue conflict of interest plays a major role, given how intertwined they are with Big Pharma and the far-reaching grasp of the BMGF. A cheap and effective early treatment for Covid-19, like ivermectin, can be seen as a significant threat to the financial interests of those involved with Covid vaccines and expensive anti-viral drugs.

Read More »

Canada: Alberta Failing on COVID-19 Vaccines and Treatment

Numerous studies and clinical observation of thousands of patients has indicated that Ivermectin is highly effective in this regard. Even low dose studies that were designed to reach the conclusion that ivermectin was not effective found a signal that indicated that Ivermectin effectively interacted with the COVID virus molecule to prevent or lessen replication of the virus.”

Read More »